Novartis to cut up to 400 jobs at Dublin campus
Weeks after CEO Vas Narasimhan unveiled a “US-first” strategy in reshaping Novartis, the Swiss pharma giant has revealed plans to cut around 400 jobs at its Dublin campus by the end of 2024.
The cuts are part of a major restructuring that Narasimhan initiated back in April, cutting out $1 billion in costs and letting go of some key execs while combining the pharmaceuticals and oncology units under one roof. In an attempt to achieve a “leaner and simpler” business, Novartis is chopping 8,000 of 108,000 current roles worldwide, a spokesperson told Endpoints News on Thursday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.